Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Mitchell | Genex | Coventry agrees to acquire QualCare
Deal will strengthen company's network in New Jersey San Diego, CA — May 11, 2021 — Mitchell | Ge
Workers' Comp
Podcast
Quality Assurance in Case Management
Workers' Comp
Article
Self-service tools can bring savings for both payers and providers
The phone in your pocket shouldn’t really be called a phone, should it? After all, making calls isn’t its primary purpose.
Mitchell
News Release
Mitchell Teams With Mazda North American Operations to Launch U.S. Collision Repair Network
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
News Release
Workerscompensation.com: Sikorsky Sees 'Dramatic Results' with Onsite RTW Program
Sarasota, FL (Workerscompensation.com) – Sikorsky, a Lockheed Martin Company, saw a 48 percent reduction in lost workdays within 9 months o
Workers' Comp
Virtual Event
Webinar: Onsite Return to Work: A Sikorsky Approach
On-Demand
Since Lockheed Martin (LMC) acquired Sikorsky, medical treatment return-to-work (RTW) protocols have been developed in collaboration with Sik